UC Davis Health joins Parkinson’s Foundation Center of Excellence
The Center for Movement Disorders and Neurorestoration at the University of California (UC) Davis Health Department of Neurology will…
Articles by Margarida Maia, PhD
BrainTale raises €4.5M to develop brain-decoding software
BrainTale raised €4.5 million (about $5 million) to speed further development of software that can decode changes in the…
Vaccine trial for early Parkinson’s meets primary objectives
UB-312, an experimental vaccine by Vaxxinity, appeared safe and well tolerated and was able to produce an immune response against…
Axial awarded second MJFF grant for gut-targeting therapy
Axial Therapeutics will use a new research grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF)…
Less active brain waves may signal cognitive decline in Parkinson’s
People with Parkinson’s disease who are experiencing cognitive decline may show weaker low-frequency brain waves on an electroencephalogram (EEG),…
MJFF grant will help Icometrix ID brain MRI biomarkers in Parkinson’s
A grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) will allow Icometrix — a company focused…
1st patient dosed in 201 trial of IkT-148009 for Parkinson’s
Inhibikase Therapeutics, which is recruiting up to 120 untreated Parkinson’s disease patients across the U.S. to test its…
Acorda, Chance enter agreement to sell Inbrija in China
Acorda Therapeutics has entered into an agreement with Chance Pharmaceuticals for Inbrija (levodopa inhalation powder), a medication…
Inhibikase takes steps ahead of ‘201’ study of IkT-148009 in Parkinson’s
A once-daily 200 mg dose of IkT-148009, Inhibikase Therapeutics‘ investigational therapy for Parkinson’s disease, reached steady levels in…
FDA needs additional information before approval of ABBV-951
The U.S. Food and Drug Administration (FDA) has requested more information about the specialized pump used to administer ABBV-951…